Comparing family-based telemedicine to inpatient treatment for anorexia nervosa
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
This study is testing if family-based treatment for anorexia nervosa delivered through telehealth is as effective as traditional inpatient care for teenagers with this condition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 8 Years to 17 Years |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin, State of Berlin) |
| Trial ID | NCT06759402 on ClinicalTrials.gov |
What this trial studies
The FIAT study aims to evaluate the effectiveness of Family-Based Treatment (FBT) delivered through telehealth compared to traditional inpatient multimodal therapy (IMT) for patients with anorexia nervosa. Conducted across 21 hospitals in Germany, this interventional study will assess treatment outcomes and health economic data to inform future guidelines and reimbursement policies for FBT. Participants will include adolescents with restrictive and bulimic subtypes of anorexia nervosa who meet specific eligibility criteria, including a stable internet connection for telehealth participation.
Who should consider this trial
Good fit: Ideal candidates are adolescents with anorexia nervosa who require inpatient treatment and have a stable internet connection.
Not a fit: Patients with severe weight loss, acute self-harm, or other significant psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more accessible and effective treatment option for adolescents with anorexia nervosa.
How similar studies have performed: Other studies have shown promise in using telehealth for mental health treatments, suggesting potential success for this approach, though this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01) * inpatient treatment indication according to S3 guideline * weight \< 3. BMI-percentile or * weight \<10. percentile and psychiatric comorbidity/rapid weight loss/lack of weight gain during outpatient treatment over last three month * planned inpatient treatment * insured with one of the participating health insurance companies * stable internet connection Exclusion Criteria: * weight \<67%mBMI * acute self harm or danger to others * acute psychosis or suicidal tendencies * current substance abuse * child abuse or domestic violence in the family * insured with other health insurance company * judicial placement order for inpatient treatment * known, currently existing child protection problems or proceedings by the family court
Where this trial is running
Berlin, State of Berlin
- Charité- Universitätsmedizin Berlin — Berlin, State of Berlin, Germany (Recruiting)
Study contacts
- Principal investigator: Christoph U Correll, MD — Charite University, Berlin, Germany
- Study coordinator: Verena K. Haas, Dr. oec. troph.
- Email: verena.haas@charite.de
- Phone: +4930 450 566 399
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.